New director makes Onyx more Jolly
This article was originally published in Scrip
CMO Onyx Scientific has appointed Dr Brian Jolly director of European business development. Dr Jolly has spent over 25 years in a range of technical and commercial roles in speciality chemicals and the wider chemicals industry.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.